Respiratory stimulant drugs in the post-operative setting

Respiratory Physiology and Neurobiology

Volumn 189, Issue 2, 2013, Pages 395-402

  Golder, Francis J ^a   Hewitt, Matthew M ^a   McLeod, James F ^a  

^a Galleon Pharmaceuticals   (United States)

Author keywords

Analeptic; Anesthesia; Hypoxia; Opioid; Surgery; Ventilation

Indexed keywords

ALMITRINE; ALMITRINE DIMESILATE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPAKINE; DOXAPRAM; GAL 021; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; NALOXONE; PIPERAZINE DERIVATIVE; RESPIRATORY STIMULANT AGENT; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ACTION POTENTIAL; ANALGESIA; ANESTHESIA COMPLICATION; ARTIFICIAL VENTILATION; CALCIUM CURRENT; CALCIUM TRANSPORT; CARDIOVASCULAR EFFECT; CAROTID BODY; CAROTID SINUS NERVE; CENTRAL NERVOUS SYSTEM DEPRESSION; CHEMORECEPTOR; CHEMOSENSITIVITY; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIARRHEA; DRUG BLOOD LEVEL; DRUG INDUCED DISEASE; DRUG INDUCED RESPIRATORY DEPRESSION; DRUG OVERDOSE; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; ELEVATED BLOOD PRESSURE; FATIGUE; HEADACHE; HUMAN; HYPERTENSION; HYPOVENTILATION; IC 50; INSOMNIA; ION CURRENT; LD 50; LUNG ALVEOLUS HYPOVENTILATION; LUNG GAS EXCHANGE; LUNG VENTILATION; MALAISE; MEMBRANE STEADY POTENTIAL; NAUSEA; NEWBORN APNEA; NONHUMAN; PATIENT CARE; PERIPHERAL NEUROPATHY; PHASE 1 CLINICAL TRIAL (TOPIC); POSITIONAL DIZZINESS; POSITIVE END EXPIRATORY PRESSURE; POSTOPERATIVE COMPLICATION; PRESSOR RESPONSE; PRIORITY JOURNAL; RECOVERY ROOM; RESPIRATION CONTROL; RESPIRATION DEPRESSION; RESPIRATORY DRIVE; REVIEW; SHIVERING; SIDE EFFECT; SLEEP DISORDERED BREATHING; STRUCTURE ACTIVITY RELATION; SYSTEMIC VASCULAR RESISTANCE; WEIGHT REDUCTION;

ANALEPTIC; ANESTHESIA; HYPOXIA; OPIOID; SURGERY; VENTILATION;

HUMANS; POSTOPERATIVE COMPLICATIONS; PULMONARY VENTILATION; RESPIRATORY INSUFFICIENCY; RESPIRATORY SYSTEM AGENTS;

EID: 84886233432     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2013.06.010     Document Type: Review

References (125)

1. Abelson J.L., Nesse R.M., Weg J.G., Curtis G.C. Respiratory psychophysiology and anxiety: cognitive intervention in the doxapram model of panic. Psychosomatic Medicine 1996, 58:302-313.
2. Abelson J.L., Weg J.G., Nesse R.M., Curtis G.C. Neuroendocrine responses to laboratory panic: cognitive intervention in the doxapram model. Psychoneuroendocrinology 1996, 21:375-390.
3. Albertson T.E., Stark L.G., Joy R.M. The effects of doxapram, diazepam, phenobarbital and pentylenetetrazol on suprathreshold and threshold stimulations in amygdaloid kindled rats. Neuropharmacology 1983, 22:245-248.
4. Allen M.B. Almitrine and peripheral neuropathy. Lancet 1988, 2:571.
5. Allen M.B., Prowse K. Peripheral nerve function in patients with chronic bronchitis receiving almitrine or placebo. Thorax 1989, 44:292-297.
6. Ansquer J.C. Vectarian international multicenter study (VIMS) in hypoxemic chronic bronchitis patients treated by the double-blind placebo method for 1 year. Follow-up of the monitoring of 490 patients. Revue de Médecine Interne 1985, 6(Spec No):31-37.
7. Ansquer J.C., Bertrand A., Blaive B., Charpin J., Chretien J., Decroix G., Kalb J.C., Lissac J., Michel F.B., Morere P., et al. Therapeutic importance and tolerance of coated 50mg Vectarion tablets (almitrine bismesylate) at a dosage of 100mg/day. Study of blood gas, clinical and biological results after a year of long-term treatment. Revue Des Maladies Respiratoires 1985, 2(Suppl. 1):S61-S67.
8. Baby S.M., Golder F.J., Gruber R.B., Puskovic V., Hoskins P.A., Dax S.L., Peng S., Wardle R.L., Van Scott M.R., MacIntyre D.E., Mannion J.C. Reversal of opioid-induced respiratory depression by GAL-021, a novel respiratory stimulant. American Journal of Respiratory and Critical Care Medicine 2012, 185:A2442.
9. Baby S.M., Golder F.J., Peng S., Dax S.L., MacIntyre D.E., Mannion J.C. GAL-021-induced respiratory stimulation is associated with increases in carotid sinus nerve and phrenic motoneuron activity in rats. The FASEB Journal 2012, 26:704-729.
10. Bairam A., Blanchard P.W., Mullahoo K., Beharry K., Laudignon N., Aranda J.V. Pharmacodynamic effects and pharmacokinetic profiles of keto-doxapram and doxapram in newborn lambs. Pediatric Research 1990, 28:142-146.
11. Bairam A., Faulon M., Monin P., Vert P. Doxapram for the initial treatment of idiopathic apnea of prematurity. Biology of the Neonate 1992, 61:209-213.
12. Barer G.R., Bee D., Wach R.A., Gill G.W., Dhillon D.P., Suggett A.J., Evans T.W. Does almitrine bismesylate improve V/Q matching? An animal study. European Journal of Respiratory Diseases: Supplement 1983, 126:209-214.
13. Bleul U., Bircher B., Jud R.S., Kutter A.P. Respiratory and cardiovascular effects of doxapram and theophylline for the treatment of asphyxia in neonatal calves. Theriogenology 2010, 73:612-619.
14. Bleul U., Bylang T. Effects of doxapram, prethcamide and lobeline on spirometric, blood gas and acid-base variables in healthy new-born calves. Veterinary Journal 2012, 194:240-246.
15. Bouche P., Lacomblez L., Leger J.M., Chaunu M.P., Ratinahirana H., Brunet P., Hauw J.J., Cathala H.P., Laplane D. Peripheral neuropathies during treatment with almitrine: report of 46 cases. Journal of Neurology 1989, 236:29-33.
16. Boyle J., Stanley N., James L.M., Wright N., Johnsen S., Arbon E.L., Dijk D.J. Acute sleep deprivation: the effects of the AMPAKINE compound CX717 on human cognitive performance, alertness and recovery sleep. Journal of Psychopharmacology 2012, 26:1047-1057.
17. Brown K.A., Laferriere A., Lakheeram I., Moss I.R. Recurrent hypoxemia in children is associated with increased analgesic sensitivity to opiates. Anesthesiology 2006, 105:665-669.
18. Buckler K.J. TASK-like potassium channels and oxygen sensing in the carotid body. Respiratory Physiology & Neurobiology 2007, 157:55-64.
19. Burki N.K. Ventilatory effects of doxapram in conscious human subjects. CHEST Journal 1984, 85:600.
20. Calverley P.M., Robson R.H., Wraith P.K., Prescott L.F., Flenley D.C. The ventilatory effects of doxapram in normal man. Clinical Science (London) 1983, 65:65-69.
21. Campbell D.B., Gordon B., Taylor A., Taylor D., Williams J. The biodisposition of almitrine bismesylate in man: a review. European Journal of Respiratory Diseases: Supplement 1983, 126:337-348.
22. Chang P.K., Verbich D., McKinney R.A. AMPA receptors as drug targets in neurological disease-advantages, caveats, and future outlook. European Journal of Neuroscience 2012, 35:1908-1916.
23. Cotten J.F., Keshavaprasad B., Laster M.J., Eger E.I., Yost C.S. The ventilatory stimulant doxapram inhibits TASK tandem pore (K2P) potassium channel function but does not affect minimum alveolar anesthetic concentration. Anesthesia & Analgesia 2006, 102:779-785.
24. de Backer W., Bogaert E., Van Maele R., Vermeire P. Effect of almitrine bismesylate on arterial blood gases and ventilatory drive in patients with severe chronic airflow obstruction and bilateral carotid body resection. European Journal of Respiratory Diseases: Supplement 1983, 126:239-242.
25. De Backer W., Vermeire P., Bogaert E., Janssens E., Van Maele R. Almitrine has no effect on gas exchange after bilateral carotid body resection in severe chronic airflow obstruction. Bulletin Européen de Physiopathologie Respiratoire 1985, 21:427-432.
26. Dempsey J.A., Smith C.A., Blain G.M., Xie A., Gong Y., Teodorescu M. Role of central/peripheral chemoreceptors and their interdependence in the pathophysiology of sleep apnea. Advances in Experimental Medicine and Biology 2012, 758:343-349.
27. Dhillon D.P., Barer G.R. Respiratory stimulation by almitrine during acute or chronic hypoxia/hypercapnia in rats. Bulletin Européen de Physiopathologie Respiratoire 1982, 18:751-764.
28. Doufas A.G., Tian L., Padrez K.A., Suwanprathes P., Cardell J.A., Maecker H.T., Panousis P. Experimental pain and opioid analgesia in volunteers at high risk for obstructive sleep apnea. PLoS One 2013, 8:e54807.
29. Fagerlund M.J., Kahlin J., Ebberyd A., Schulte G., Mkrtchian S., Eriksson L.I. The human carotid body: expression of oxygen sensing and signaling genes of relevance for anesthesia. Anesthesiology 2010, 113:1270-1279.
30. Flandrois R., Guerin J.C. Action of almitrine on chemoreflex control of ventilation in healthy subjects and chronic respiratory insufficiency. Revue Francaise des Maladies Respiratoires 1980, 8:561-567.
31. Forster H.V., Bisgard G.E., Rasmussen B., Orr J.A., Buss D.D., Manohar M. Ventilatory control in peripheral chemoreceptor-denervated ponies during chronic hypoxemia. Journal of Applied Physiology 1976, 41:878-885.
32. Franko B.V., Ward J.W. Nikethamide and doxapram effects on pentazocine- and morphine-induced respiratory depression. Journal of Pharmacy and Pharmacology 1971, 23:709-710.
33. Funk G.D., Smith J.C., Feldman J.L. Generation and transmission of respiratory oscillations in medullary slices: role of excitatory amino acids. Journal of Neurophysiology 1993, 70:1497-1515.
34. Gasser J.C. Interaction between morphine and doxapram. British Journal of Anaesthesia 1977, 49:952.
35. Gay G.R., Kirkman J.H., Alexander G.A., Rappolt R.T. Modification of cardiopressor and respirogenic effects of doxapram by propranolol. Clinical Toxicology 1978, 13:487-504.
36. Gherardi R., Belec L., Louarn F. Almitrine-induced peripheral neuropathy and weight loss. Journal of Neurology 1989, 236:374.
37. Gluskowski J., Gorecka D., Hawrylkiewicz I., Zielinski J. Acute effects of almitrine infusion on pulmonary haemodynamics in normal man. Bulletin Européen de Physiopathologie Respiratoire 1984, 20:313-317.
38. Gluskowski J., Gorecka D., Hawrylkiewicz I., Zielinski J. Effect of almitrine on normal pulmonary circulation. Polski Tygodnik Lekarski 1985, 40:733-736.
39. Goff D.C., Lamberti J.S., Leon A.C., Green M.F., Miller A.L., Patel J., Manschreck T., Freudenreich O., Johnson S.A. A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacology 2008, 33:465-472.
40. Golder F.J., Baby S.M., Gruber R.B., Puskovic V., Dax S.L., Peng S., MacIntyre E., Mannion J.C. Enantiomeric separation of doxapram reveals the (+)-enantiomer (GAL-054) to be a superior respiratory stimulant with an improved therapeutic index. American Journal of Respiratory and Critical Care Medicine 2012, 185:A3616.
41. Golder F.J., Gruber R.B., Baby S.M., Puskovic V., Ideo C.M., Peng S., Dax S.L., MacIntyre D.E., Mannion J.C. Enantiomeric separation of doxapram reveals a superior respiratory stimulant, GAL-054. The FASEB Journal 2012, 26. 894.822.
42. Golder F.J., Gruber R.B., Puskovic V., Peng S., Dax S.L., MacIntyre D.E., Mannion J.C. Reversal of opioid-induced respiratory depression by the (+)-enantiomer, GAL-054, but not the (-)-enantiomer, GAL-053, of doxapram. The FASEB Journal 2012, 26:704-726.
43. Golder F.J., Wardle R.L., Van Scott M.R., Hoskins P.A., Dax S.L., Peng S., MacIntyre D.E., Mannion J.C. GAL-021 acts as a novel respiratory stimulant in non-human primates. The FASEB Journal 2012, 26:704-727.
44. Greer J.J., Smith J.C., Feldman J.L. Role of excitatory amino acids in the generation and transmission of respiratory drive in neonatal rat. Journal of Physiology 1991, 437:727-749.
45. Gregoretti S.M., Pleuvry B.J. Interactions between morphine and doxapram in the rabbit and mouse. British Journal of Anaesthesia 1977, 49:323-329.
46. Gruber R.B., Golder F.J., Dax S.L., Peng S., MacIntyre D.E., Mannion J.C. The effects of almitrine on hypoxic and opioid-induced respiratory depression. The American Thoracic Society Annual Meeting 2011, A5280.
47. Hackett P.H., Roach R.C., Harrison G.L., Schoene R.B., Mills W.J. Respiratory stimulants and sleep periodic breathing at high altitude. Almitrine versus acetazolamide. American Review of Respiratory Disease 1987, 135:896-898.
48. Hamlyn E., Brand L., Shahid M., Harvey B.H. The ampakine, Org 26576, bolsters early spatial reference learning and retrieval in the Morris water maze: a subchronic, dose-ranging study in rats. Behavioural Pharmacology 2009, 20:662-667.
49. Hillidge C.J. The use of Dopram as a respiratory stimulant following Immobilon in the pony. Equine Veterinary Journal 1976, 8:173-175.
50. Howard P. Almitrine bismesylate (Vectarion). Bulletin Européen de Physiopathologie Respiratoire 1984, 20:99-103.
51. Huffington P., Craythorne N.W. Effect of doxapram on heart rhythm during anesthesia in dog and man. Anesthesia & Analgesia 1966, 45:558-563.
52. Hughes J.M., Allison D.J., Goatcher A., Tripathi A. Action of almitrine bismesylate on pulmonary vasculature in the dog: preliminary report. European Journal of Respiratory Diseases: Supplement 1983, 126:215-224.
53. Hughes J.M., Allison D.J., Goatcher A., Tripathi A. Influence of alveolar hypoxia on pulmonary vasomotor responses to almitrine in the dog. Clinical Science (London) 1986, 70:555-564.
54. Jensen E.C., Klemm W.R. Clinical evaluation of the analeptic, doxapram, in dogs and cats. Journal of the American Veterinary Medical Association 1967, 150:516-525.
55. Khanna V.K., Pleuvry B.J. A study of naloxone and doxapram as agents for the reversal of neuroleptanalgesic respiratory depression in the conscious rabbit. British Journal of Anaesthesia 1978, 50:905-912.
56. Kim S.I., Winnie A.P., Collins V.J., Shoemaker W.C. Hemodynamic responses to doxapram in normovolemic and hypovolemic dogs. Anesthesia & Analgesia 1971, 50:705-710.
57. Komatsu R., Sengupta P., Cherynak G., Wadhwa A., Sessler D.I., Liu J., Hurst H.E., Lenhardt R. Doxapram only slightly reduces the shivering threshold in healthy volunteers. Anesthesia & Analgesia 2005, 101:1368-1373.
58. Kumar P. Systemic effects resulting from carotid body stimulation-invited article. Advances in Experimental Medicine and Biology 2009, 648:223-233.
59. Lambropoulos S., Chatzipappas A., Tsekos G., Tsantoulis K. The role of almitrine bismesylate in acute respiratory failure. European Journal of Respiratory Diseases: Supplement 1986, 146:657-661.
60. Laubie M., Schmitt H. Long-lasting hyperventilation induced by almitrine: evidence for a specific effect on carotid and thoracic chemoreceptors. European Journal of Pharmacology 1980, 61:125-136.
61. Laxenaire M.C., Boileau S., Dagrenat P., Menu N., Drouet N. Haemodynamic and respiratory effects of post-operative doxapram and almitrine in patients following pneumonectomy. European Journal of Anaesthesiology 1986, 3:259-271.
62. Lopez-Lopez J.R., Perez-Garcia M.T., Canet E., Gonzalez C. Effects of almitrine bismesylate on the ionic currents of chemoreceptor cells from the carotid body. Molecular Pharmacology 1998, 53:330-339.
63. Lorier A.R., Funk G.D., Greer J.J. Opiate-induced suppression of rat hypoglossal motoneuron activity and its reversal by ampakine therapy. PLoS One 2010, 5:e8766.
64. Lotsch J., Skarke C., Schneider A., Hummel T., Geisslinger G. The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depression. Clinical Pharmacology & Therapeutics 2005, 78:278-287.
65. Lugliani R., Whipp B.J., Wasserman K. Doxapram hydrochloride: a respiratory stimulant for patients with primary alveolar hypoventilation. Chest 1979, 76:414-419.
66. MacLeod C.N., Thomas R.W., Bartley E.A., Parkhurst G.W., Bachand R.T. Effects and handling of almitrine bismesylate in healthy subjects. European Journal of Respiratory Diseases: Supplement 1983, 126:275-289.
67. MacNee W., Connaughton J.J., Rhind G.B., Hayhurst M.D., Douglas N.J., Muir A.L., Flenley D.C. A comparison of the effects of almitrine or oxygen breathing on pulmonary arterial pressure and right ventricular ejection fraction in hypoxic chronic bronchitis and emphysema. American Review of Respiratory Disease 1986, 134:559-565.
68. Mangin P., Krieger J., Kurtz D. Effect of oral almitrine on the sleep apnea syndrome. Revue Francaise des Maladies Respiratoires 1983, 11:899-906.
69. Marsac J. The assessment of almitrine bismesylate in the long-term treatment of chronic obstructive bronchitis. European Journal of Respiratory Diseases: Supplement 1986, 146:685-693.
70. Mathie A., Veale E.L. Therapeutic potential of neuronal two-pore domain potassium-channel modulators. Current Opinion in Investigational Drugs 2007, 8:555-562.
71. Melot C., Dechamps P., Hallemans R., Decroly P., Mols P. Enhancement of hypoxic pulmonary vasoconstriction by low dose almitrine bismesylate in normal humans. American Review of Respiratory Disease 1989, 139:111-119.
72. Melot C., Naeije R., Hallemans R., Mols P., Lejeune P. Beneficial effects of almitrine bismesylate on pulmonary gas exchange in COPD. European Journal of Respiratory Diseases: Supplement 1983, 126:249-254.
73. Melot C., Naeije R., Rothschild T., Mertens P., Mols P., Hallemans R. Improvement in ventilation-perfusion matching by almitrine in COPD. Chest 1983, 83:528-533.
74. Mitchell R.A., Herbert D.A. Potencies of doxapram and hypoxia in stimulating carotid-body chemoreceptors and ventilation in anesthetized cats. Anesthesiology 1975, 42:559-566.
75. Miyata M., Hata T., Kato N., Takeuchi M., Mizutani H., Kubota M., Yamazaki T. Dynamic QT/RR relationship of cardiac conduction in premature infants treated with low-dose doxapram hydrochloride. Journal of Perinatal Medicine 2007, 35.
76. Mkrtchian S., Kahlin J., Ebberyd A., Gonzalez C., Sanchez D., Balbir A., Kostuk E.W., Shirahata M., Fagerlund M.J., Eriksson L.I. The human carotid body transcriptome with focus on oxygen sensing and inflammation-a comparative analysis. Journal of Physiology 2012, 590:3807-3819.
77. Murphy D.J., Renninger J.P., Schramek D. Respiratory inductive plethysmography as a method for measuring ventilatory parameters in conscious, non-restrained dogs. Journal of Pharmacological and Toxicological Methods 2010, 62:47-53.
78. Naeije R., Melot C., Mols P., Hallemans R., Naeije N., Cornil A., Sergysels R. Effects of almitrine in decompensated chronic respiratory insufficiency. Bulletin Européen de Physiopathologie Respiratoire 1981, 17:153-161.
79. Nakayama H. Effect of ventilatory drive on carbon dioxide sensitivity below eupnea during sleep. American Journal of Respiratory and Critical Care Medicine 2002, 165:1251-1260.
80. Nardi A.E., Freire R.C., Zin W.A. Panic disorder and control of breathing. Respiratory Physiology & Neurobiology 2009, 167:133-143.
81. Nishino T., Mokashi A., Lahiri S. Stimulation of carotid chemoreceptors and ventilation by doxapram in the cat. Journal of Applied Physiology 1982, 52:1261-1265.
82. O'Halloran K.D., Curran A.K., Bradford A. Effect of almitrine on ventilation and on diaphragm and geniohyoid muscle activity in the rat. Clinical Science (London) 1996, 91:337-345.
83. Oertel B.G., Felden L., Tran P.V., Bradshaw M.H., Angst M.S., Schmidt H., Johnson S., Greer J.J., Geisslinger G., Varney M.A., Lotsch J. Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia. Clinical Pharmacology & Therapeutics 2010, 87:204-211.
84. Oertel B.G., Schneider A., Rohrbacher M., Schmidt H., Tegeder I., Geisslinger G., Lotsch J. The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans. Clinical Pharmacology & Therapeutics 2007, 81:59-68.
85. Overdyk F.J., Carter R., Maddox R.R., Callura J., Herrin A.E., Henriquez C. Continuous oximetry/capnometry monitoring reveals frequent desaturation and bradypnea during patient-controlled analgesia. Anesthesia & Analgesia 2007, 105:412-418.
86. Parotte P., Boileau S., Marchand G., Laxenaire M.C. Effects of a respiratory analeptic with peripheral action-almitrine on ventilation immediately after surgery. Annales de l'Anesthesiologie Francaise 1980, 21:519-524.
87. Peers C. Effects of doxapram on ionic currents recorded in isolated type I cells of the neonatal rat carotid body. Brain Research 1991, 568:116-122.
88. Peers C., O'Donnell J. Potassium currents recorded in type I carotid body cells from the neonatal rat and their modulation by chemoexcitatory agents. Brain Research 1990, 522:259-266.
89. Peers C., Wyatt C.N., Evans A.M. Mechanisms for acute oxygen sensing in the carotid body. Respiratory Physiology & Neurobiology 2010, 174:292-298.
90. Ramamurthy S., Steen S.N., Winnie A.P. Doxapram antagonism of meperidine-induced respiratory depression. Anesthesia & Analgesia 1975, 54:352-356.
91. Randall N.P., Pleuvry B.J., Fazackerley E.J., Modla C.Y., Prescott L.F., Healy T.E. Effect of oral doxapram on morphine-induced changes in the ventilatory response to carbon dioxide. British Journal of Anaesthesia 1989, 62:159-163.
92. Reeder M.K., Goldman M.D., Loh L., Muir A.D., Casey K.R., Lehane J.R. Late postoperative nocturnal dips in oxygen saturation in patients undergoing major abdominal vascular surgery. Predictive value of pre-operative overnight pulse oximetry. Anaesthesia 1992, 47:110-115.
93. Reeder M.K., Goldman M.D., Loh L., Muir A.D., Foex P., Casey K.R., McKenzie P.J. Postoperative hypoxaemia after major abdominal vascular surgery. British Journal of Anaesthesia 1992, 68:23-26.
94. Ren J., Ding X., Funk G.D., Greer J.J. Ampakine CX717 protects against fentanyl-induced respiratory depression and lethal apnea in rats. Anesthesiology 2009, 110:1364-1370.
95. Ren J., Ding X., Greer J.J. Respiratory depression in rats induced by alcohol and barbiturate and rescue by ampakine CX717. Journal of Applied Physiology 2012, 113:1004-1011.
96. Ren J., Poon B.Y., Tang Y., Funk G.D., Greer J.J. Ampakines alleviate respiratory depression in rats. American Journal of Respiratory and Critical Care Medicine 2006, 174:1384-1391.
97. Russo E., Gitto R., Citraro R., Chimirri A., De Sarro G. New AMPA antagonists in epilepsy. Expert Opinion on Investigational Drugs 2012, 21:1371-1389.
98. Sah P. Ca(2+)-activated K+ currents in neurones: types, physiological roles and modulation. Trends in Neurosciences 1996, 19:150-154.
99. Saupe K.W., Smith C.A., Henderson K.S., Dempsey J.A. Respiratory muscle recruitment during selective central and peripheral chemoreceptor stimulation in awake dogs. Journal of Physiology 1992, 448:613-631.
100. Sergysels R., Naeije R., Mols P., Hallemans R., Melot C. Dissociation between ventilation and blood gas under almitrine perfusion in patients suffering from chronic obstructive bronchopneumopathy. Revue Francaise des Maladies Respiratoires 1980, 8:577-585.
101. Shapiro A., Zohar E., Zaslansky R., Hoppenstein D., Shabat S., Fredman B. The frequency and timing of respiratory depression in 1524 postoperative patients treated with systemic or neuraxial morphine. Journal of Clinical Anesthesia 2005, 17:537-542.
102. Singh P., Dimitriou V., Mahajan R.P., Crossley A.W. Double-blind comparison between doxapram and pethidine in the treatment of postanaesthetic shivering. British Journal of Anaesthesia 1993, 71:685-688.
103. Smith P.D., Gotz V.P., Ryerson G.G. Almitrine bismesylate. Drug Intelligence & Clinical Pharmacy 1987, 21:417-421.
104. Stanley N.N., Galloway J.M., Gordon B., Pauly N. Increased respiratory chemosensitivity induced by infusing almitrine intravenously in healthy man. Thorax 1983, 38:200-204.
105. Stephen C.R., Talton I. Investigation of doxapram as a postanesthetic respiratory stimulant. Anesthesia & Analgesia 1964, 43:628-640.
106. Stephen C.R., Talton I. Effects of doxapram on the electrocardiogram during anesthesia. Anesthesia & Analgesia 1966, 45:783-789.
107. Suggett A.J., Jarratt J.A., Proctor A., Howard P. Almitrine and peripheral neuropathy. Lancet 1985, 2:830-831.
108. Suratt P.M., Wilhoit S.C., Brown E.D., Findley L.J. Effect of doxapram on obstructive sleep apnea. Bulletin Européen de Physiopathologie Respiratoire 1986, 22:127-131.
109. Takahashi T., Osanai S., Nakano H., Ohsaki Y., Kikuchi K. Doxapram stimulates the carotid body via a different mechanism than hypoxic chemotransduction. Respiratory Physiology & Neurobiology 2005, 147:1-9.
110. Taylor S., Kirton O.C., Staff I., Kozol R.A. Postoperative day one: a high risk period for respiratory events. American Journal of Surgery 2005, 190:752-756.
111. Tweney J. Almitrine bismesylate: current status. Bulletin Européen de Physiopathologie Respiratoire 1987, 23(Suppl. 11):153s-163s.
112. Tweney J., Howard P. Almitrine bismesylate. Zeitschrift fur Erkrankungen der Atmungsorgane 1987, 168:197-215.
113. Vasu T.S., Grewal R., Doghramji K. Obstructive sleep apnea syndrome and perioperative complications: a systematic review of the literature. Journal of Clinical Sleep Medicine 2012, 8:199-207.
114. Ward J.W., Franko B.V. A new centrally acting agent (AHR-619) with marked respiratory stimulating, pressor, and "awakening" effects. Federation Proceedings 1962, 21:325.
115. Ward J.W., Gilbert D.L., Franko B.V., Woodard G., Mann G.T. Toxicological studies of doxapram hydrochloride. Toxicology and Applied Pharmacology 1968, 13:242-250.
116. Waters K.A., McBrien F., Stewart P., Hinder M., Wharton S. Effects of OSA, inhalational anesthesia, and fentanyl on the airway and ventilation of children. Journal of Applied Physiology 2002, 92:1987-1994.
117. Weese-Mayer D.E., Brouillette R.T., Klemka L.M., Hunt C.E. Effects of almitrine on genioglossal and diaphragmatic electromyograms. Journal of Applied Physiology 1986, 61:2122-2128.
118. Weese-Mayer D.E., Klemka L.M., Brouillette R.T., Hunt C.E. Effects of almitrine on respiration in unanesthetized newborn rabbits. Journal of Applied Physiology 1988, 64:817-822.
119. Wernette K.M., Hubbell J.A., Muir W.W., Sams R.A. Doxapram: cardiopulmonary effects in the horse. American Journal of Veterinary Research 1986, 47:1360-1362.
120. Wezenberg E., Verkes R.J., Ruigt G.S., Hulstijn W., Sabbe B.G. Acute effects of the ampakine farampator on memory and information processing in healthy elderly volunteers. Neuropsychopharmacology 2007, 32:1272-1283.
121. Wilkinson K.A., Huey K., Dinger B., He L., Fidone S., Powell F.L. Chronic hypoxia increases the gain of the hypoxic ventilatory response by a mechanism in the central nervous system. Journal of Applied Physiology 2010, 109:424-430.
122. Yamanaka Y., Shimada T., Mochizuki R., Suzuki Y., Takenouchi K., Takeda T., Uno H., Izawa Y., Fujiwara K. Neuronal and muscular inclusions in rats with hindlimb dysfunction after treating with difluorobenzhydrylpiperadine. Toxicologic Pathology 1997, 25:150-157.
123. Yost C.S. A new look at the respiratory stimulant doxapram. CNS Drug Reviews 2006, 12:236-249.
124. Yue H.J., Guilleminault C. Opioid medication and sleep-disordered breathing. Medical Clinics of North America 2010, 94:435-446.
125. Zutler M., Holty J.E. Opioids, sleep, and sleep-disordered breathing. Current Pharmaceutical Design 2011, 17:1443-1449.